Sponda Plc to publish segment data according to a new

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Apr 3, 2017 at 3:00 AM 43

Sponda Plc to publish segment data according to a new reporting structure from 2016

Sponda Plc Stock Exchange Release 3 April 2017 at 9:05 a.m.

Sponda Plc to publish segment data according to a new reporting structure from 2016

Sponda's interim report for January-March 2017 will be published on Friday 5 May 2017 according to the new financial reporting structure. The organisational change was announced in a stock exchange release on 21 November 2016. From 1 January 2017, Sponda's reporting segments are as follows: Office Properties, Shopping Centres, Property Development, Non-Strategic Holdings and the Other segment. The Non-Strategic Holdings segment includes the remaining logistics properties, properties in Russia and the current Property Investment Companies segment. The Other segment includes expenses not allocated to any of the Group's businesses.

The comparable figures according to the new segment division are presented in the tables below.

1-3/2016, MEUR	Office Properties	Shopping Centres	Property Development	Non-Strategic Holdings	Other	Group, total

Total revenue	40.0	14.1	0.2	4.9	0.0	59.3
Maintenance expenses and direct fund expenses	-11.6	-3.0	-0.5	-2.2	0.0	-17.2
Net operating income	28.4	11.1	-0.2	2.8	0.0	42.1
Profit on sales of investment properties	0.2	-	-	0.0	-	0.2
Loss on sales of investment properties	-	-	-	0.0	-	0.0
Profit/loss on disposal of associated companies	-	-	-	-	-	-
Profit/loss on trading properties	-	-	12.5	-	-	12.5
Valuation gains/losses on fair value assessment	1.1	0.2	1.7	-5.0	-	-2.0
Amortisation of goodwill	-	-	-0.6	-	0.0	-0.6
Administration and marketing	-3.0	-0.9	-1.1	-0.6	-0.1	-5.7
Other operating income and expenses	0.1	-0.1	0.0	0.1	0.2	0.3
Operating profit	26.7	10.3	12.3	-2.7	0.1	46.7

Investments	166.3	427.9	12.1	0.2	0.0	606.6
Segment assets	2,168.6	1,161.7	154.6	262.0	151.7	3,898.6
- of which classified as held for sale	3.6	-	-	5.7	-	9.3
Economic Occupancy Rate	88.1	93.8	-	77.4	-	88.7

1-6/2016, MEUR	Office Properties	Shopping Centres	Property Development	Non-Strategic Holdings	Other	Group, total

Total revenue	82.8	33.3	0.6	10.2	0.1	126.9
Maintenance expenses and direct fund expenses	-22.3	-7.2	-1.2	-4.0	0.0	-34.6
Net operating income	60.5	26.1	-0.6	6.2	0.1	92.3
Profit on sales of investment properties	0.2	-	-	0.2	-	0.4
Loss on sales of investment properties	-	-	-0.4	-	0.0	-0.4
Profit/loss on disposal of associated companies	-	-	-	-	-	-
Profit/loss on trading properties	-	-	12.5	-	0.0	12.5
Valuation gains/losses on fair value assessment	12.6	6.2	3.9	-19.7	-	3.0
Amortisation of goodwill	-	-	-1.3	-	0.0	-1.3
Administration and marketing	-5.7	-1.9	-2.1	-1.3	-0.4	-11.4
Other operating income and expenses	0.1	-0.1	0.1	0.1	0.2	0.5
Operating profit	67.6	30.3	12.2	-14.5	-0.1	95.6

Investments	171.2	430.1	24.3	1.8	0.0	627.5
Segment assets	2,185.0	1,177.1	159.6	247.1	143.0	3,911.8
- of which classified as held for sale	8.6	-	-	13.5	-	22.1
Economic Occupancy Rate	88.3	94.2	-	78.5	-	89.1

1-9/2016, MEUR	Office Properties	Shopping Centres	Property Development	Non-Strategic Holdings	Other	Group, total

Total revenue	125.3	51.8	1.0	14.9	0.2	193.2
Maintenance expenses and direct fund expenses	-31.7	-10.7	-1.7	-5.4	0.0	-49.5
Net operating income	93.6	41.1	-0.6	9.6	0.1	143.8
Profit on sales of investment properties	0.2	-	-	1.2	-	1.4
Loss on sales of investment properties	-0.1	-	-0.4	0.0	0.0	-0.5
Profit/loss on disposal of associated companies	-	-	-	-0.1	-	-0.1
Profit/loss on trading properties	-	-	13.3	-	0.0	13.3
Valuation gains/losses on fair value assessment	10.8	-1.5	4.7	-21.0	-	-7.0
Amortisation of goodwill	-	-	-2.1	-	0.0	-2.1
Administration and marketing	-8.3	-2.8	-3.0	-1.9	-0.3	-16.4
Other operating income and expenses	0.0	0.0	0.0	0.1	0.2	0.3
Operating profit	96.2	36.8	11.9	-12.1	0.1	132.8

Investments	176.8	431.6	41.0	2.1	0.1	651.7
Segment assets	2,183.9	1,170.9	176.7	232.6	80.7	3,844.8
- of which classified as held for sale	30.2	-	-	8.5	-	38.7
Economic Occupancy Rate	88.8	93.2	-	79.8	-	89.3

1-12/2016, MEUR	Office Properties	Shopping Centres	Property Development	Non-Strategic Holdings	Other	Group, total

Total revenue	167.2	70.3	1.3	20.0	0.2	259.0
Maintenance expenses and direct fund expenses	-43.1	-15.5	-2.2	-7.3	0.0	-68.0
Net operating income	124.1	54.8	-0.9	12.7	0.1	190.9
Profit on sales of investment properties	0.7	-	-	1.2	-	2.0
Loss on sales of investment properties	-0.1	-	-0.4	-0.7	0.0	-1.1
Profit/loss on disposal of associated companies	-	-	-	-0.1	-	-0.1
Profit/loss on trading properties	-	-	14.6	-	0.0	14.6
Valuation gains/losses on fair value assessment	25.2	21.3	4.9	-24.8	-	26.7
Amortisation of goodwill	-	-	-3.1	-	0.0	-3.1
Administration and marketing	-11.5	-4.0	-4.2	-2.6	-0.5	-22.8
Other operating income and expenses	-0.1	-0.2	-0.4	0.1	0.2	-0.4
Operating profit	138.4	72.0	10.5	-14.1	-0.1	206.7
Financial income and expenses					-51.2	-51.2
Profit before taxes					-51.3	155.5
Income taxes					-17.9	-17.9
Profit/loss for period					-69.3	137.5

Investments	187.1	433.3	60.7	4.3	0.3	685.6
Segment assets	2,203.8	1,195.4	196.0	226.7	94.5	3,916.5
- of which classified as held for sale	10.6	-	3.3	19.0	-	32.8
Economic Occupancy Rate	89.2	93.5	-	79.9	-	89.6

Sponda Plc Further information: Niklas Nylander, Chief Financial Officer, tel. +358 20 431 3480 or +358 40 754 5961 Pia Arrhenius, Senior Vice President, Corporate Planning and IR, tel. +358 20 431 3454 or +358 40 527 4462

Sponda Plc is a property investment company specialising in commercial properties in the largest cities in Finland. Sponda's business concept is to own, lease and develop retail and office properties and shopping centres into environments that promote the business success of its clients. The fair value of Sponda's investment properties is approximately EUR 3.8 billion and the leasable area is around 1.2 million m².

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...